Investor Presentaiton

ེསེ (1) (2) Includes states with medical cannabis programs in which Curaleaf operates. BDS Analytics, June 2020. + Patient Metrics (Medical Only) (1) CORE, STABLE MEDICAL REVENUE CURALEAF'S MEDICAL CANNABIS BUSINESS FEATURES STRONG, PREDICTABLE REVENUES MEDICAL REVENUES CONTINUE TO PROVIDE A STABLE BASE EVEN AFTER A STATE BEGINS ADULT-USE SALES S ($ in millions) Colorado Cannabis Sales (2) $450.00 $375.00 $300.00 $225.00 $150.00 $75.00 MAR 2020 Active Patients Visits / Month Spend / Visit Gross Revenue ($ in millions) 95,470 X 2.32 X $97.87 2 $21.7M Adult-Use Medical Nevada Cannabis Sales (2) $180.00 MAR 2019 54,242 X 2.22 X $90.25 2 $10.9M $150.00 $120.00 $90.00 $60.00 $30.00 $- 2017 2017 2018 Q3 Q4 Q1 2018 2018 2018 2019 2019 2019 Q2 Q3 Q4 Q1 Q2 2019 2020 Q3 Q4 Q1 Adult-Use Medical 2014 Q1 2014 Q2 2014 Q3 2014 Q4 2015 Q1 2015 Q2 2015 Q3 2015 Q4 2016 Q1 2016 Q2 2016 Q3 2016 Q4 curaleaf. 12 2017 Q1 2017 Q2 2017 Q3 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1

View entire presentation